BiotechTube
Home/Tirmed Pharma/Leo Holmgren
LH

Leo Holmgren

CEO

Tirmed Pharma

Therapeutic Areas

DermatologyImmunology

Tirmed Pharma Pipeline

DrugIndicationPhase
TIR-01Atopic Dermatitis (mild to moderate)Pre-clinical

Leadership Team at Tirmed Pharma

PA
Prof. Anna-Lena Spetz
CSO, Founder
DP
Dr. Pirkko Tamsen
Clinical Development & Regulatory Lead
AP
Assoc. Prof. Jan-Erik Nyström
IP & Business Strategy
View full Tirmed Pharma profile